This inventor holds 1 USPTO granted patent. Top assignees: Bangalore University, National University of Singapore, University of Cambridge. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3 
1 out of 854 
1 out of 439 
Years Active: 2017
Title: Innovations by Xiaoyun Dai in Cancer Treatment
Introduction
Xiaoyun Dai is an accomplished inventor based in Singapore, known for her significant contributions to the field of cancer research. With a focus on the modulation of the JAK-STAT pathway, her work aims to develop effective anti-cancer agents.
Latest Patents
Xiaoyun Dai holds a patent for "Compounds as modulator of JAK-STAT pathway, methods and applications thereof." This patent describes a compound of structural Formula I and outlines a method for preparing these compounds. The disclosure further details the use of these compounds for modulating the Janus kinase-Signal Transducer and Activator of Transcription (JAK-STAT) pathway in cancer cells, highlighting their potential as anti-cancer agents. She has 1 patent to her name.
Career Highlights
Throughout her career, Xiaoyun has worked with prestigious institutions, including the University of Mysore and the National University of Singapore. Her research has contributed to advancements in understanding cancer mechanisms and developing therapeutic strategies.
Collaborations
Xiaoyun has collaborated with notable colleagues, including Kanchugarakoppal Subbegowda Rangappa and Basappa, enhancing her research through shared expertise and insights.
Conclusion
Xiaoyun Dai's innovative work in cancer treatment through the modulation of the JAK-STAT pathway showcases her dedication to advancing medical science. Her contributions are paving the way for new therapeutic options in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile